Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
2015 StandoutNatureNobel
Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening
2013
Cross-protection by MF59™-adjuvanted influenza vaccine: Neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses
2008
A systematic review of brain injury epidemiology in Europe
2005
Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents
2012
Naturally occurring mutations associated with resistance to HCV NS5B polymerase and NS3 protease inhibitors in treatment-naïve patients with chronic hepatitis C
2015
Prevalence of chronic liver disease in the general population of northern Italy: The dionysos study
1994
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
2015 Standout
Characteristics of hepatocellular carcinoma in Italy
1998
Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines
2013 StandoutNobel
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
2003 Standout
Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination
1996
Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects
2001
Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination
2015 StandoutNobel
Toxoplasmosis snapshots: Global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis
2009 Standout
Safety Review: Squalene and Thimerosal in Vaccines
2010
Hepatitis B Virus Infection: Epidemiology and Vaccination
2006 Standout
A robust cell culture system supporting the complete life cycle of hepatitis B virus
2017 StandoutNobel
The importance of HCV on the burden of chronic liver disease in Italy: A multicenter prevalence study of 9,997 cases
2005
Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects
2003
Burden of liver diseases in the world
2018 Standout
Sexual dimorphism of humoral immunity with human vaccines
2008
Hepatitis B Virus Infection
2008
Molecular Tracing of the Global Hepatitis C Virus Epidemic Predicts Regional Patterns of Hepatocellular Carcinoma Mortality
2006
Changing epidemiology of parenterally transmitted viral hepatitis: results from the hepatitis surveillance system in Italy
2001
Open, Randomized Study to Compare the Immunogenicity and Reactogenicity of an Influenza Split Vaccine with an MF59-Adjuvanted Subunit Vaccine and a Virosome-Based Subunit Vaccine in Elderly
2004
Hepatocellular carcinoma
2012 Standout
Hepatitis B virus infection
2009 Standout
Mucosal immunity and vaccines
2005 Standout
MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile
2003
Long-Term Course of Chronic Hepatitis C in Children: From Viral Clearance to End-Stage Liver Disease
2008
Risk Factors for Hepatitis C Virus Transmission to Health Care Workers after Occupational Exposure: A European Case-Control Study
2005
The annual impact of seasonal influenza in the US: Measuring disease burden and costs
2007 Standout
Hepatitis B vaccines
2003
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
The changing epidemiology of hepatitis C virus infection in Europe
2007
Hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine: a review of HEPLISAV™ safety and efficacy
2011
Hepatitis B Virus Infection in Native versus Immigrant or Adopted Children in Italy Following the Compulsory Vaccination
2001
Global epidemiology of hepatitis C virus infection
2005 Standout
A Prospective, Comparative Study of the Immune Response to Inactivated Influenza Vaccine in Pediatric Liver Transplant Recipients and Their Healthy Siblings
2008
Management of Hepatocellular Carcinoma *
2005 Standout
Recent advances with liposomes as pharmaceutical carriers
2005 Standout
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
2004 Standout
Hepatitis C Virus Infection in Pregnancy
2020
A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvant
1999
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
2004 Standout
Vaccine adjuvants – understanding molecular mechanisms to improve vaccines
2014 StandoutNobel
The impact of the hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy
2000
Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement
2011
Seroprevalencia de anticuerpos frente a Treponema pallidum, Toxoplasma gondii, virus de la rubéola, virus de la hepatitis B y C y VIH en mujeres gestantes
2004
Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection
2010
Chronic hepatitis B
2007 Standout
A New MF59-Adjuvanted Influenza Vaccine Enhances the Immune Response in the Elderly with Chronic Diseases: Results from an Immunogenicity Meta-Analysis
2003
Chronic hepatitis B: Update 2009 #
2009 Standout
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
2012 Standout
Interferons and viruses: an evolutionary arms race of molecular interactions
2015 StandoutNobel
The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population
2006 Standout
Virosomal adjuvanted antigen delivery systems
2003
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
2015 StandoutNobel
Vaccination greatly reduces disease, disability, death and inequity worldwide
2008 Standout
Antibody response to influenza vaccination in the elderly: A quantitative review
2005
Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study
2009
Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory
2000
Influenza vaccine immunology
2010
Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality
2009
Sexually transmitted diseases treatment guidelines
2003 Standout
Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates
2010
Development of RTS,S/AS02: a purified subunit-based malaria vaccine candidate formulated with a novel adjuvant
2003
Moderate and severe traumatic brain injury in adults
2008 Standout
Low Incidence and Prevalence of Hepatitis C Virus Infection Among Sexually Active Non-Intravenous Drug-Using Adults, San Francisco, 1997–2000
2003
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Sex differences in immune responses
2016 Standout
Microneedles for drug and vaccine delivery
2012 Standout
Acute Hepatitis C: A Systematic Review.
2008
Unsafe Sex and Increased Incidence of Hepatitis C Virus Infection among HIV-Infected Men Who Have Sex with Men: The Swiss HIV Cohort Study
2005
Immunization programme against hepatitis B virus infection in Italy: cost-effectiveness
1999
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
2006 Standout
Hepatocellular Carcinoma
2011 Standout
NAFLD: A multisystem disease
2015 Standout
Comparison of the immunogenicity and safety ofCervarix™ andGardasil®human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years
2009
Enhanced Immunogenicity of Seasonal Influenza Vaccines in Young Children Using MF59 Adjuvant
2009
MF59®-adjuvanted influenza vaccine (FLUAD®) in children: Safety and immunogenicity following a second year seasonal vaccination
2009
The burden of liver disease in Europe: A review of available epidemiological data
2013
Adjuvanted influenza vaccines
2012
Inflammasomes in health and disease
2012 StandoutNature
epic3: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in England
2013 Standout
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Microparticles as vaccine adjuvants and delivery systems
2003
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
2020 Standout
Mucosal adjuvants and delivery systems for protein‐, DNA‐ and RNA‐based vaccines
2004
Estimating the global incidence of traumatic brain injury
2018 Standout
Residues in a Highly Conserved Claudin-1 Motif Are Required for Hepatitis C Virus Entry and Mediate the Formation of Cell-Cell Contacts
2009
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Hepatitis C virus polyprotein vaccine formulations capable of inducing broad antibody and cellular immune responses
2006 StandoutNobel
Systematic review and economic decision modelling for the prevention and treatment of influenza A and B
2003
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Claudins and the Modulation of Tight Junction Permeability
2013 Standout
Safety and Immunogenicity of Two Influenza Virus Subunit Vaccines, with or without MF59 Adjuvant, Administered to Human Immunodeficiency Virus Type 1-Seropositive and -Seronegative Adults
2007
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59
2011
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel
Detailed Computational Study of the Active Site of the Hepatitis C Viral RNA Polymerase to Aid Novel Drug Design
2013 StandoutNobel
Correlates of Protection Induced by Vaccination
2010 Standout
Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2001 Standout
Works of R. Trivello being referenced
Baseline sero-epidemiology of hepatitis B virus infection in children and teenagers in Italy. A survey before mass hepatitis B vaccination
1991
Epidemiology of HCV Infection
2008
Hepatitis C virus infection in homosexual men: A seroepidemiological study in gay clubs in North-East Italy
1991
Long-term persistence of anti-HBs after vaccination against HBV: an 18 year experience in health care workers
2003
Hepatitis C virus, hepatitis B virus and human immunodeficiency virus infection in pregnant women in North-East Italy: A seroepidemiological study
2000
Intrafamilial Transmission of Hepatitis C Virus Infection
2006
Immunogenicity of Three Different Influenza Vaccines against Homologous and Heterologous Strains in Nursing Home Elderly Residents
2010
Influenza vaccines: antibody responses to split virus and MF59-adjuvanted subunit virus in an adult population.
1999
Prevalence of Antibodies against Hepatitis C Virus in the Elderly: A Seroepidemiological Study in a Nursing Home and in an Open Population
2000
Response of Influenza Vaccines Against Heterovariant Influenza Virus Strains in Adults with Chronic Diseases
2007
Occupational Risk of Blood-Borne Viruses in Healthcare Workers: A 5-Year Surveillance Program
2002
Comparison of three different influenza vaccines in institutionalised elderly
2001
Persistence of anti-HBs antibodies in health care personnel vaccinated with plasma-derived hepatitis B vaccine and response to recombinant DNA HB booster vaccine
1995
MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18–60 years of age) with chronic diseases who are at risk of post-influenza complications
2007
Epidemiological aspect of traumatic brain injury in Northeast Italy
2003
HBV and HCV infection among non-European Union immigrants in North-East Italy
1998
Changing Epidemiology of HCV and HBV Infections in Northern Italy
2008
Two different dosages of yeast derived recombinant hepatitis B vaccines: a comparison of immunogenicity
1996
Changing pattern of hepatitis B infection in children: a comparative seroepidemiological study (1979 vs 1989) in north-east Italy.
1992